Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells
Current immunotherapeutics typically work by directing elements of the immune system to acknowledge biomarkers on the floor of most cancers
Read more